Federal contract award

75N93021F00002

ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NIAID
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Parent award / vehicle75N93020D00011
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$11.2M
Current contract value$11.2M
Potential contract value / ceiling$11.2M
Start dateSep 30, 2021
Current end dateSep 29, 2026
Potential end dateSep 29, 2026
Latest award activityJul 21, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Sep 10, 2026P00009$-16.5KANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING OF CANDIDATE MCMS
Jul 21, 2026P00008$117.9KANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING OF CANDIDATE MCMS
Jul 16, 2026P00007$-117.9KTO ADMINISTRATE DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.
Jun 17, 2025P00006$0ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING
Aug 31, 2023P00005$0ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING
May 17, 2022P00004$0ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING
Apr 14, 2022P00003$0ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING
Feb 10, 2022P00002$0ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING
Oct 29, 2021P00001$0ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING
Sep 20, 20210$11.2MANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.